Therapy Areas: Devices
FDA Advisory Committee votes in favour of GRAIL's Galleri multi-cancer early detection test
24 September 2026 - GRAIL Inc, a healthcare company focused on early cancer detection,, announced on Wednesday a favourable vote from the Molecular and Clinical Genetics Devices Panel of the Medical D...
Insmed's ARIKAYCE sNDA granted priority review by FDA
21 September 2026 - Biopharmaceutical company Insmed Incorporated (Nasdaq: INSM) disclosed on Monday that the US Food and Drug Administration has accepted its supplemental New Drug Application for ARI...
ProBio and Kun Tuo collaborate to deliver integrated CDMO-CRO solutions for advanced therapies
17 September 2026 - ProBio Inc, a global contract development and manufacturing organisation (CDMO) involved in biologics and cell and gene therapies (CGT), announced on Wednesday a strategic collabor...
Myosin Therapeutics chosen for 2026-2027 NCI Investor Initiatives Showcase
17 September 2026 - Myosin Therapeutics Inc, a clinical-stage biotechnology company developing a new class of therapies targeting cancer cell mechanics, announced on Thursday its selection as a 2026&n...
Medtronic receives FDA clearance for LigaSure RAS Maryland instrument on Hugo system
16 September 2026 - Healthcare technology company Medtronic (NYSE: MDT) announced on Wednesday that it has received US Food and Drug Administration clearance for its LigaSure RAS Maryland jaw device f...
Aptar and Aceso Therapeutics partner to advance inhaled cystic fibrosis therapy
7 September 2026 - Aptar Pharma, a provider of drug delivery, dosing, protection technologies and services and part of AptarGroup Inc (NYSE:ATR), announced on Monday that it has partnered with Aceso T...